
Browsing restrictions can be lifted for a fee.
Taiwan Fertilizer Co., Ltd., together with its subsidiaries, manufactures and sells inorganic and organic fertilizers, and other chemical products in Taiwan, the Middle East, and internationally. It provides fertilizer products, such as ammonium sulfate, urea, granular phosphate, calcium ammonium nitrate, single super phosphate, potassium chloride, potassium sulfate, organic and nitro phosphate, biotec organic compound fertilizers, organic fertilizers, instant water-soluble fertilizers, taifer biopower stimulants, and dolomite products. The company also offers chemical products, including urea for industrial applications, melamine, sulfamic acid, anhydrous ammonia, nitric acid, sulfuric acid, and oleum. In addition, it provides electronic and precision chemicals products, such as hydrochloric, nitric, sulfuric, phosphoric, and acetic acid; and ammonium water, sodium and potassium hydroxide, hydrogen peroxide, photoresist stripper, dimethyl sulfoxide, monoethanolamine, isopropyl alcohol, acetone, n-methyl-2-pyrrolidone, cyclopentanone, edge bead remover, and propylene glycol methyl ether and ether acetate. Further, the company engages development and leasing of real estate; wholesale of beverages, foods, and cosmetics; and wholesale of fertilizer, as well as gas station and health businesses. Taiwan Fertilizer Co., Ltd. was incorporated in 1946 and is headquartered in Taipei, Taiwan.
1722
台肥
-0.21%
(-0.00)
The most recent financial report for 台肥 (1722) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1722's short-term business performance and financial health. For the latest updates on 1722's earnings releases, visit this page regularly.
According to historical valuation range analysis, 台肥 (1722)'s current price-to-earnings (P/E) ratio is 30.72, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 台肥 (1722) reported an Operating Profit of 115.61M with an Operating Margin of 3.83% this period, representing a decline of 32.05% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 台肥 (1722) announced revenue of 3.02B, with a Year-Over-Year growth rate of 2.2%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 台肥 (1722) held Total Cash and Cash Equivalents of 2.97B, accounting for 0.04 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 台肥 (1722) achieved the “three margins increasing” benchmark, with a gross margin of 13.85%%, operating margin of 3.83%%, and net margin of 18.6%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1722's profit trajectory and future growth potential.
According to the past four quarterly reports, 台肥 (1722)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.57. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
台肥 (1722)'s Free Cash Flow (FCF) for the period is 539.76M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 541.56% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.